The trademark application DALICARE was filed by DALI Pharma GmbH, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on June 14, 2021, and it was registered by office on September 21, 2021 without any oppositions.
The application was filed in English (German was selected as the second language).
A transfer of the trademark registration was recorded on November 13, 2022. Appointment and Replacement of representative of the trademark registration was recorded on October 2, 2023.